Initially depicted in 1973 by Ralph Steinman and Zanvil Cohn, dendritic cells (DCs) have a fundamental job of interfering with intrinsic insusceptible reactions and fostering a flexible immune response. From that point forward, DCs were viewed as the most intense antigen-displaying cells (APCs), frequently referred to as “Nature’s adjuvant,” designed to initiate credulous and memory-resistant reactions. In terms of securing and managing antigens for introduction to T cells, DCs have a prevalent limit and express abnormal quantities of costimulatory or coinhibitory atoms that determine secure initiation or anergy1. Right about 40 years after that, when the Nobel Prize for Medicine or Physiology was awarded to Ralph Steinman in 2011 for his disclosure of these essential natural immune cells, the importance of DCs was perceived.
This immunotherapy treatment helps the body battle cancer cells with its own defense mechanism. Dendritic cell therapy is often used when regular therapies have not been effective. As of late, this treatment was proposed in India and multiple patients were relieved under the supervision of the renowned Oncologist with empowering results. Be that as it may, there are common drugs that have been developed over decades for most forms of tumor. Usage of these drugs is administered and combined with unsusceptible care, since it is realized that tumor cells weakened by chemotherapy or radiation are considerably easier to decimate with invulnerable cells than with flawless tumor cells.
Type of cancer treated with dendritic cell based immunotherapy treatment
- Skin cancer
- Kidney cancer
- Breast cancer
- Pancreatic cancer
- Colon cancer
- Ovarian cancer
- Prostrate cancer
Stage IV cancer treatment
Dendritic cell based immunotherapy treatment has proved to be quite a success specially with no hope stage IV cancer treatment. Patients specially on stage IV cancer can try and go for dendritic cell based immunotherapy in cancer treatment.
Hospitals for dendritic cell based immunotherapy treatment in India
- LDG India Ltd, Gurugram
- APAC Biotech, Noida
- Dendritic cell research, New Delhi
Cost of dendritic cell based immunotherapy treatment in India
Cost of dendritic cell based immunotherapy treatment may vary from $ 8000 USD – $ 15,000 USD depending upon stage of cancer and treating doctor and hospital.
